Abstract
We have examined the induction of hypodense eosinophils by platelet-activating factor (PAF), a mediator which may be involved in eosinophil activation in allergic diseases. Guinea-pig eosinophils were incubated with buffer or PAF and applied to continuous Percoll density gradients. Cellular density ranged from 1.0142 to 1.1369 g/ml. Peak eosinophil density in control was 1.0887 +/- 0.0008 g/ml (mean +/- SEM), and 91.1 +/- 1.4% of eosinophils were distributed between 1.0810 and 1.1000 g/ml. Preincubation of eosinophils with PAF(10(-7) M) resulted in a time-dependent and non-cytolytic increase of the number of hypodense eosinophils, with peak densities after incubation for 1 hr and 2 hr of 1.0834 +/- 0.0014 (n = 4, P less than 0.05) and 1.0755 +/- 0.0007 g/ml (n = 6, P less than 0.01), respectively. After incubation for 2 hr, 82.0 +/- 4.9% (n = 6) eosinophils showed a density lower than 1.080 g/ml. Lyso-PAF, the inactive precursor and metabolite of PAF, at a concentration of 10(-7) M had no effect on cell density. The specific PAF receptor antagonist WEB 2086 (10(-6) M) inhibited the PAF-induced density shift by 87.0 +/- 5.3%. Our results demonstrate that a single mediator is able to induce the formation of hypodense eosinophils. We conclude that the appearance of hypodense eosinophils in allergic diseases such as asthma may occur, at least in part, in response to inflammatory mediators which activate these cells.
MeSH Terms
Animals
Azepines/pharmacology
Centrifugation, Density Gradient
Eosinophils/drug effects
Guinea Pigs
Platelet Activating Factor/antagonists & inhibitors,pharmacology
Triazines/pharmacology
Triazoles
Chemicals
Azepines
Platelet Activating Factor
Triazines
Triazoles
WEB 2086
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Yukawa T
Department of Thoracic Medicine, Brompton Hospital, London, U.K.
Kroegel C
Evans P
Fukuda T
Chung K F
Barnes P J
References (24)
24 references, click to expand
-
Increased biosynthesis of platelet-activating factor in activated human eosinophils.
J Biol Chem. 1984 May 10;259(9):5526-30
PMID: 6425292
-
Role of IgE receptors in effector function of human eosinophils.
J Immunol. 1984 Jan;132(1):462-8
PMID: 6228581
-
Increased numbers of hypodense eosinophils in the blood of patients with bronchial asthma.
Am Rev Respir Dis. 1985 Nov;132(5):981-5
PMID: 4062053
-
Release of leukotriene C4 from human eosinophils and its relation to the cell density.
Int Arch Allergy Appl Immunol. 1985;78(4):406-10
PMID: 3934084
-
Role of specific IgE antibodies in peroxidase (EPO) release from human eosinophils.
J Immunol. 1986 Sep 1;137(5):1659-64
PMID: 3489038
-
Platelet-activating factor (PAF-acether) induced leukotriene C4 formation and luminol dependent chemiluminescence by human eosinophils.
Pharmacol Res Commun. 1986 Aug;18 Suppl:61-9
PMID: 3774850
-
Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
J Clin Invest. 1986 Dec;78(6):1701-6
PMID: 3023451
-
Leukotriene C4 production by normal-density and low-density eosinophils of atopic individuals and other patients with eosinophilia.
J Allergy Clin Immunol. 1987 Apr;79(4):611-9
PMID: 3558998
-
The effects of eosinophil activating factor on IgG-dependent sulphidopeptide leukotriene generation by human eosinophils.
Clin Exp Immunol. 1986 Dec;66(3):673-80
PMID: 3568455
-
Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts.
J Exp Med. 1987 Jul 1;166(1):129-41
PMID: 3110347
-
Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
J Pharmacol Exp Ther. 1987 Jun;241(3):974-81
PMID: 3598913
-
The presence of hypodense eosinophils and diminished chemiluminescence response in asthma.
J Allergy Clin Immunol. 1988 Feb;81(2):429-37
PMID: 2828452
-
Hypereosinophilic syndrome: case report and morphometric study.
Acta Haematol. 1988;79(2):107-11
PMID: 3124468
-
Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet-activating factor.
J Immunol. 1988 May 1;140(9):3161-6
PMID: 3361129
-
Platelet-activating factor as a mediator of allergic disease.
J Allergy Clin Immunol. 1988 May;81(5 Pt 1):919-34
PMID: 3286723
-
Hypodense eosinophils in allergic rhinitis.
J Allergy Clin Immunol. 1988 Jul;82(1):119-25
PMID: 2899103
-
Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils.
Immunology. 1988 Jul;64(3):559-61
PMID: 3410498
-
Characterization of platelet-activating factor-induced elevation of cytosolic free calcium concentration in eosinophils.
FEBS Lett. 1989 Jan 16;243(1):41-6
PMID: 2920824
-
Stimulation of degranulation from human eosinophils by platelet-activating factor.
J Immunol. 1989 May 15;142(10):3518-26
PMID: 2541198
-
PAF-receptors on eosinophils: identification with a novel ligand, [3H]WEB 2086.
Biochem Pharmacol. 1989 May 15;38(10):1702-5
PMID: 2543419
-
Human eosinophils and parasitic diseases. II. Characterization of two cell fractions isolated at different densities.
Clin Exp Immunol. 1982 Apr;48(1):249-55
PMID: 7083641
-
Altered density, metabolism and surface receptors of eosinophils in eosinophilia.
Immunology. 1982 Nov;47(3):531-9
PMID: 7129529
-
Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia.
Int Arch Allergy Appl Immunol. 1983;72(4):336-46
PMID: 6417030
-
Heterogeneity of human eosinophils. II. Variability of respiratory burst activity related to cell density.
Clin Exp Immunol. 1984 Sep;57(3):735-42
PMID: 6467687